The Second Affiliated Hospital of Anhui Medical University — Hefei, Anhui

Public research footprint of The Second Affiliated Hospital of Anhui Medical University, compiled from the ClinicalTrials.gov public registry.

132

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Cancer · Metastatic Esophageal Squamous Cell Carcinoma · Type 2 Diabetes Mellitus (T2DM) · HER2-positive Advanced Breast Cancer

Recently updated registry entries

NCT06997497 — A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People… (Recruiting)
NCT07740564 — Phase III Study of OT202 in Treating Moderate to Severe Dry Eye (Not Yet Recruiting)
NCT04194775 — A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Second Affiliated Hospital of Anhui Medical University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.